Page 6 - Us Market

Sensex tanks 872pts, Nifty gives up 17,500 amid global sell-off; ITC shines

CLOSING BELL: Tata Steel fell over 4 per cent, while Asian Paints, Wipro, L&T, Bajaj twins, Ultratech Cement, Axis Bank, Sun Pharma, Tech M, ICICI Bank, & SBI declined in the range of 2-3.5 per cent

Wockhardt ties up with various partners to roll out products in US market

Drug firm Wockhardt on Saturday said it has tied up with various partners to roll out products in the US market with its Illinois-based manufacturing plant all set to relieve all workers in a phased manner as part of business restructuring in the US market. The Mumbai-based company said it has engaged multiple US Food and Drug Administration (USFDA) approved manufacturing partners in the US market, after thorough due diligence and inspection of their facilities, to manufacture various products for sale in the US/ North America. "The company is relieving all its staff who were directly engaged by our US subsidiary in its plant in connection with the manufacturing process in a phased manner and in full compliance with the applicable local laws," Wockhardt Ltd said in a regulatory filing. This new arrangement is in the best interest of the company as it will help avoid the manufacturing and quality management cost completely resulting in significant savings in operating and overhead co

Berkshire Hathaway seeks to buy as much as 50% of Occidental Petroleum

Berkshire has spent this year wagering more on Occidental after first making a bet on the Houston-based oil company three years ago

Secret to enduring stagflation sends investors to emerging markets

Stocks and bonds of poorer nations have sunk this year amid Federal Reserve tightening and runaway consumer prices, and may sell off even more if the global economy stalls

Oil extends losing streak on fears Fed hike will dampen fuel demand

Oil prices dropped on Monday, extending a recent losing streak on concerns that an expected rise in US interest rates would weaken fuel demand

Ronnie Screwvala-led upGrad eyeing acquisitions in the US, Southeast Asia

As part of the acquisition strategy, upGrad Rekrut, a 100 per cent subsidiary of upGrad, has acquired Wolves India, a recruitment and staffing firm, for an undisclosed amount

Gland Pharma rides high on valuation comfort, strong growth prospects

Target prices post brokerage upgrades point to more upsides

Don't retreat to home turf due to US market correction, experts advise

Benefits like low correlation, currency hedge, and access to unique businesses remain intact

US consumer sentiment near 11-year low; import prices unchanged in April

Consumer sentiment index falls 9.4% to 59.1 in May. Import prices unchanged in April; up 12.0% year-on-year

Aurobindo, Sun Pharma, Jubilant recall products in US market: USFDA

Leading drug firms Aurobindo Pharma, Sun Pharma and Jubilant are recalling different products in the US market for various reasons

Earnings boost Wall Street while economic growth fears sink oil prices

Of the 49 companies in the S&P 500 that have reported quarterly earnings as of Tuesday, nearly 80% have topped profit estimates, per Refinitiv data

Gold prices steady as dollar dip counters Fed rate hike expectations

(Reuters) - Gold steadied on Wednesday, with a weaker dollar offsetting pressure from higher U.S. Treasury yields as investors await the first pandemic-era U.S. Federal Reserve interest rate hike.

Lupin launches generic medication, to be manufactured in Nagpur, in US

Drug maker Lupin on Tuesday said it has launched Sevelamer Hydrochloride tablets (800 mg), used to treat hyperphosphatemia in patients with chronic kidney disease, in the US market

World stocks higher on strong tech amid mixed US earnings, weak eco reports

Crude oil eyed seven-year highs and the dollar eased. On Wall Street, the Dow Jones Industrial Average rose 0.63% and the S&P 500 gained 0.94%.

Morgan Stanley board lifts CEO Gorman's pay to $35 million

Since taking over a decade ago, the 63-year-old CEO has transformed Morgan Stanley from a Wall Street firm focused on a money-losing trading businesses into a more balanced bank

Explained: What Covid-19 pandemic therapies are available in US?

The U.S. recently added two new weapons to its small arsenal against the coronavirus: pills that patients can take at home to treat COVID-19. The drugs from Pfizer and Merck join a handful of other therapies that have been shown to blunt the worst effects of the virus. But each treatment has different advantages and tends to work best for certain types of patients at different stages of the disease. Here's a look at the current COVID-19 drugs and how they are used: PILLS The prescription pills are the first COVID-19 therapies that don't require infusions or injections delivered by health professionals. The Food and Drug Administration authorized Pfizer's Paxlovid on Wednesday and Merck's molnupiravir on Thursday. Merck's drug is for adults with a positive COVID-19 test, early symptoms and who face the highest risks of hospitalization. Pfizer's is for anyone 12 and older who likewise face the highest risks of hospitalization. Pfizer's drug is likely to become the first-choice tre

Honda Motorcycle starts export of NAVi bike to the US market

Honda Motorcycle & Scooter India (HMSI) on Tuesday said Honda de Mxico has initiated exports of NAVi bike to the US market. HMSI had commenced export of NAVI CKD kits to Mexico in July 2021 and has so far dispatched over 5,000 kits to the country. "The NAVi deliveries to the US market via Honda Mexico has further strengthened our export portfolio in advanced markets, the new expansion has given us an opportunity yet again to set new standards of global manufacturing quality in India," HMSI Managing Director, President and CEO Atsushi Ogata said in a statement. Honda NAVi is a crossover, which combines the advantages of a scooter with the characteristics of a motorcycle. The product that originated from India is garnering a cult following with great success in overseas markets. HMSI started NAVi exports in 2016. Since then, the company has dispatched over 1.8 lakh to 22 diverse export markets led by Asia, Middle East and Latin America.

Cipla receives USFDA nod to market Lanreotide injection in US market

Drug major Cipla on Sunday said it has received approval from the US health regulator to market the Lanreotide injection, used for the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumors, in the American market.

A brave new world of banking

The idea that a bank's lending function must be separate from its monetary function is gaining traction in the US

Analysis: Why the Federal Reserve might welcome a bond market tantrum

Even with growth tipped to surpass 6% this year and a "taper" in sight for the Fed's bond-buying programme at the end of this year, 10-year yields are still stuck at just above 1.3%